C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest

Molecular Endocrinology

Volumn 13, Issue 1, 1999, Pages 82-90

  Sharma, Kamal ^a   Patel, Yogesh C ^a   Srikant, Coimbatore B ^b  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOSTATIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CYTOSTASIS; CYTOTOXICITY; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0032894032     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.1.0220     Document Type: Article

References (47)

1. Cheung NW, Boyages SC 1995 Somatostatin-14 and its analog octreotide exert a cytostatic effect on GH3 rat pituitary tumor cell proliferation via a transient G0/G1 cell cycle block. Endocrinology 136:4174-4181
2. Candi E, Melino G, De Laurenzi V, Piacentini M, Guerreri P, Spinedi A, Knight RA 1995 Tamoxifen and somatostatin affect tumors by inducing apoptosis. Cancer Lett 96:141-145
3. Pagliacci MC, Tognellini R, Grignani F, Nicoletti I 1991 Inhibition of human breast cancer cell (MCF-7) growth in vitro by the somatostatin analog SMS 201-995: Effects on cell cycle parameters and apoptotic cell death. Endocrinology 129:2555-2562
4. Sharma K, Srikant CB 1998 Induction of aild type p53, Bax and a cation-insensitive acidic endonuclease during somatostatin signaled apoptosis in MCF-7 human breast cancer cells. Int J Cancer 76:259-266
5. Srikant CB 1995 Cell cycle dependent induction of apoptosis by somatostatin analog SMS 201-995 in AtT-20 mouse pituitary cells. Biochem Biophys Res Commun 209:400-406
6. Patel YC, Greenwood MT, Panetta R, Demchyshyn L, Niznik H, Srikant CB 1995 The somatostatin receptor family. Life Sci 57:1249-1265
7. Patel YC, Greenwood M, Panetta R, Hukovic N, Grigorakis S, Robertson LA, Srikant CB 1996 Molecular biology of somatostatin receptor subtypes. Metabolism 45:31-38
8. Bruno JF, Xu Y, Berelowitz M 1994 Somatostatin regulates somatostatin receptor subtype mRNA expression in GH3 cells. Biochem Biophys Res Commun 202:1738-1743
9. Patel YC, Panetta R, Escher E, Greenwood M, Srikant CB 1994 Expression of multiple somatostatin receptor genes in AtT-20 cells. Evidence for a novel somatostatin-28 selective receptor subtype. J Biol Chem 269:1506-1509
10. Xu Y, Song J, Berelowitz M, Bruno JF 1996 Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells. Endocrinology 137:5634-5640
11. Sharma K, Patel YC, Srikant CB 1996 Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Mol Endocrinol 10:1688-1696
12. Sharma K, Srikant CB 1998 G protein-coupled receptor signaled apoptosis is associated with induction of a cat-ion-insensitive acidic endonuclease and intracellular acidification. Biochem Biophys Res Commun 242:134-140
13. Sharma K, Patel YC, Srikant CB, Subtype selective human somatostatin receptor (h SSTR) mediated cytostatic and cytotoxic actions involve different signaling mechanisms. Program of the 77th Annual Meeting of The Endocrine Society, Minneapolis, MN, 1997, p 172 (Abstract P-152)
14. Buscail L, Esteve JP, Saint-Laurent N, Bertrand V, Reisine T, O'Carroll AM, Bell GI, Schally AV, Vaysse N, Susini C 1995 Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc Natl Acad Sci USA 92:1580-1584
15. Buscail L, Delesque N, Esteve JP, Saint-Laurent N, Prats H, Clerc P, Robberecht P, Bell GI, Liebow C, Schally AV, Vaysse N, Susini C 1994 Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: Mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci USA 91:2315-2319
16. Florio T, Scorizello A, Fattore M, VDA, Salzano S, Rossi G, Berlingieri MT, Fusco A, Schettini G 1996 Somatostatin inhibits PC Cl3 thyroid cell proliferation through the modulation of phosphotyrosine activity. Impairment of the somatostatinergic effects by stable expression of E1A viral oncogene. J Biol Chem 271:6129-6136
17. Lopez F, Esteve JP, Buscail L, Delesque N, Saint-Laurent N, Vaysse N, Susini C 1996 Molecular mechanisms of antiproliferative effect of somatostatin: Involvement of a tyrosine phosphatase. Metabolism 45:14-16
18. Weinberg RA 1995 The retinoblastoma protein and cell cycle control. Cell 81:323-330
19. Sherr CJ 1993 Mammalian G1 cyclins. Cell 73:1059-1065
20. Hermeking H, Funk JO, Reichert M, Ellwart JW, Eick D 1995 Abrogation of p53-induced cell cycle arrest by c-Myc. Evidence for an inhibitor of p21(WAF1/CIP1/SDI1). Oncogene 11:1409-1415
21. Michieli P, Chedid M, Lin D, Pierce JH, Mercer We, Givol D 1994 Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54:3391-3395
22. Ookawa K, Tsuchida S, Adachi J, Yokota J 1997 Differentiation induced by RB expression and apoptosis induced by p53 expression in an osteosarcoma cell line. Oncogene 14:1389-1396
23. Baldwin JM 1994 Structure and function of receptors coupled to G proteins. Curr Opin Cell Biol 6:180-190
24. Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ 1991 Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem 60:653-688
25. Hukovic N, Panetta R, Kumar U, Rocheville M, Patel YC 1998 The cytoplasmic tail of the human somatostatin receptor type 5 is crucial for interaction with adenylyl cyclase, and in mediating desensitization and internalization. J Biol Chem 273:21416-21422
26. Yoshitomi Y, Fujii Y, Miyazaki M, Nakajima N, Inagaki N, Seino S 1997 Involvement of MAP kinase and c-fos signaling in the inhibition of cell growth by somatostatin. Am J Physiol 272:E769-E774
27. Reardon DB, Wood SL, Brautigan DL, Bell GI, Dent P, Sturgill TW 1996 Activation of a protein tyrosine phosphatase and inactivation of Raf-1 by somatostatin. Biochem J 314:401-404
28. Lopez F, Esteve JP, Buscail L, Delesque N, Saint-Laurent N, Theveniau M, Nahmias C, Vaysse N, Susini C 1997 The tyrosine phosphatase SHP-I associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling. J Biol Chem 272:24448-24454
29. Dou QP, An B, Will PL 1995 Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis. Proc Natl Acad Sci USA 92:9019-9023
30. 2+-permeable channel. Cell Calcium 22:75-82
31. 2+-dependent stimulation of retinoblastoma gene product phosphorylation and p34cdc2 kinase activation in serum-stimulated human fibroblasts. J Biol Chem 268:138-145
32. Yatsunami J, Komori A, Ohta T, Suganuma M, Fujuki H 1993 Hyperphosphorylation of retinoblastoma protein and p53 by okadaic acid, a tumor promoter. Cancer Res 53:239-241
33. Cordelier P, Esteve JP, Bousquet C, Delesque N, O'Carroll AM, Schally AV, Vaysse N, Susini C, Buscail L 1997 Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5. Proc Natl Acad Sci USA 94:9343-9348
34. Crespo P, Xu N, Simonds WF, Gutkind JS 1994 Ras-dependent activation of MAP kinase pathway is mediated by G protein βγ, subunits. Nature 369:418-420
35. ras. Proc Natl Acad Sci USA 91:12706-12710
36. Marshall CJ 1994 MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr Opin Gene Dev 4:82-89
37. Dent P, Reardon DB, Wood SL, Lindorfer MA, Graber SG, Garrison JC, Brautigan DL, Sturgill TW 1996 Inactivation of raf-1 by a protein-tyrosine phosphatase stimulated by GTP and reconstituted by Galphai/o subunits. J Biol Chem 271:3119-3123
38. Dent P, Reardon DB, Morrison DK, Sturgill TW 1995 Regulation of Raf-1 and raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro. Mol Cell Biol 15:4125-4135
39. Yao B, Zhang Y, Delikat S, Mathais S, Basu S, Kolesnick R 1995 Phosphorylation of Raf by ceramide-activated protein kinase. Nature 378:307-310
40. Cattaneo MG, Amoroso D, Gussoni G, Sanguini AM, Vicentini LM 1996 A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell lines. FEBS Lett 397:164-168
41. Ruiz-Torres P, Lucio FJ, Gonzalez-Rubio M, Rodriguez-Puyol M, Rodriguez-Puyol D 1993 A dual effect of somatostatin on the proliferation of cultured rat mesangial cells. Biochem Biophys Res Commun 195:1057-1062
42. David M, Chen HE, Goelz S, Larner AC, Neel BG 1995 Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 15:7050-7058
43. Wilkinson GF, Thurlow RJ, Sellers LA, Coote JE, Fenuik W, Humphrey PP 1996 Potent antagonism by BIM-23056 at the human recombinant somatostatin sst5 receptor Br J Pharmacol 118:445-447
44. Patel YC, Srikant CB 1994 Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr1-5). Endocrinology 135:2814-2817
45. Patel YC, Greenwood MT, Warszynska A, Panetta RP, Srikant CB 1994 All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylylcyclase. Biochem Biophys Res Commun 198:605-612
46. Srikant CB, Shen SH 1996 Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTP1C to membranes in MCF-7 human breast adenocarcinoma cells. Endocrinology 137:3461-3468
47. Zhao Z, Bouchard P, Diltz CD, Shen SH, Fischer EH 1993 Purification and characterization of a protein tyrosine phosphatase containing SH2 domains. J Biol Chem 268:2816-2820